| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10007156 | HBV | ENSG00000100994.12 | protein_coding | PYGB | No | No | 5834 | P11216 |
| TVIS30053199 | HIV | ENSG00000100994.12 | protein_coding | PYGB | No | No | 5834 | P11216 |
| TVIS20055778 | HPV | ENSG00000100994.12 | protein_coding | PYGB | No | No | 5834 | P11216 |
| TVIS44042812 | HTLV-1 | ENSG00000100994.12 | protein_coding | PYGB | No | No | 5834 | P11216 |
| TVIS44042673 | HTLV-1 | ENSG00000100994.12 | protein_coding | PYGB | No | No | 5834 | P11216 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | PYGB |
|---|---|
| DrugBank ID | DB00114 |
| Drug Name | Pyridoxal phosphate |
| Target ID | BE0002150 |
| UniProt ID | P11216 |
| Regulation Type | cofactor |
| PubMed IDs | 7916624; 8254668 |
| Citations | Hudson JW, Hefferon KL, Crerar MM: Comparative analysis of species-independent, isozyme-specific amino-acid substitutions in mammalian muscle, brain and liver glycogen phosphorylases. Biochim Biophys Acta. 1993 Jul 10;1164(2):197-208. doi: 10.1016/0167-4838(93)90248-p.@@Hudson JW, Golding GB, Crerar MM: Evolution of allosteric control in glycogen phosphorylase. J Mol Biol. 1993 Dec 5;234(3):700-21. doi: 10.1006/jmbi.1993.1621. |
| Groups | Approved; Investigational; Nutraceutical |
| Direct Classification | Pyridoxals and derivatives |
| SMILES | CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O |
| Pathways | Histidinemia; 3-Methylglutaconic Aciduria Type I; Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); beta-Ketothiolase Deficiency; Tyrosine Metabolism; Disulfiram Action Pathway; Hyperprolinemia Type II; Glutamate Metabolism; Argininosuccinic Aciduria; Tyrosinemia Type I; Hyperinsulinism-Hyperammonemia Syndrome; Porphyrin Metabolism; 2-Methyl-3-hydroxybutryl-CoA Dehydrogenase Deficiency; Glutaric Aciduria Type I; Propanoate Metabolism; Taurine and Hypotaurine Metabolism; Catecholamine Biosynthesis; Glycine and Serine Metabolism; Carnitine Synthesis; Tyrosinemia Type 3 (TYRO3); Selenoamino Acid Metabolism; Carbamoyl Phosphate Synthetase Deficiency; Hyperprolinemia Type I; Saccharopinuria/Hyperlysinemia II; Histidine Metabolism; Cystathionine beta-Synthase Deficiency; Arginine and Proline Metabolism; Starch and Sucrose Metabolism; Globoid Cell Leukodystrophy; Ammonia Recycling |
| PharmGKB | PA164749650 |
| ChEMBL | CHEMBL82202 |
